国际标准期刊号: 2278-0238

国际药学与生命科学研究与发展杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

SCREENING OF ECLIPTA ALBA EXTRACTS FOR ANTICANCER ACTIVITY

R.B Desireddy, Naga Sowjanya.G, Lavanya Latha Reddy K, Sowjanya. T.

Cancer is the second largest cause of death which killed 7.6 million people worldwide in 2005 (Danaei et al., 2005). The number is believed to become 9 million in 2015 and 11.5 million in 2030 (World Health Organization, 2007). There is an increasing interest to research and develop on new anticancer drugs, from both synthetic and natural sources (Mukherjee et al., 2001). Half of the drugs which have been approved recently are from natural sources. Plants have been extensively used as natural sources to develop anticancer drugs because of their active constituents. Medicinal plants in Asian countries play an important role in cancer treatment and indeed, their chemical constituents and derivatives have been utilized for combating cancers over the last half-century. Presently in the study Eclipta alba ethanolic plant extract has been used for screening the anti-cancer activity in-vitro and the results obtained, gives the evidence that the ethanolic extract inhibit the growth of colon cancer cells at concentrations that showed no apparent toxicity effect against normal cells.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。